Metropolitan Life Insurance Company (MetLife)’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,652
| Closed | -$23.9K | – | 497 |
|
|
2024
Q1 | $23.9K | Buy |
4,652
+161
| +4% | +$828 | ﹤0.01% | 1770 |
|
|
2023
Q4 | $25.7K | Hold |
4,491
| – | – | ﹤0.01% | 1803 |
|
|
2023
Q3 | $21.5K | Buy |
4,491
+1,213
| +37% | +$5.8K | ﹤0.01% | 1859 |
|
|
2023
Q2 | $13.9K | Hold |
3,278
| – | – | ﹤0.01% | 2119 |
|
|
2023
Q1 | $17.4K | Sell |
3,278
-354
| -10% | -$1.88K | ﹤0.01% | 1958 |
|
|
2022
Q4 | $22.8K | Hold |
3,632
| – | – | ﹤0.01% | 1940 |
|
|
2022
Q3 | $38.3K | Hold |
3,632
| – | – | ﹤0.01% | 1635 |
|
|
2022
Q2 | $19.7K | Hold |
3,632
| – | – | ﹤0.01% | 2061 |
|
|
2022
Q1 | $33.3K | Sell |
3,632
-2,065
| -36% | -$19K | ﹤0.01% | 1824 |
|
|
2021
Q4 | $86K | Hold |
5,697
| – | – | ﹤0.01% | 2555 |
|
|
2021
Q3 | $136K | Buy |
+5,697
| New | +$136K | ﹤0.01% | 2342 |
|